Panbela Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Panbela Therapeutics

13/05/2022 21:48

* Panbela Therapeutics Inc  PBLA.OQ  reported a quarterly
adjusted
loss of 27 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 25 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Panbela Therapeutics Inc's reported EPS for the quarter
was a
loss of 27 cents​.
    * The mean earnings estimate of analysts had fallen by
about 15.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Panbela Therapeutics Inc shares had fallen by 23.8% this
quarter and lost 7.1% so far this year.
    * The company reported a quarterly loss of $3.67 million.
    * Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 13 at 08:48 p.m.  ​All
figures in US dollars unless otherwise stated